Skip to main contentAI and Advanced
/
WAKEFIT · NSEBSE SENSEX76,132.81-0.50%BSE |
NIFTY 5023,779.15-0.50%NSE |
NIFTY BANK57,088.3-0.49%NSE |
NIFTY IT29,995.2-2.28%NSE |
NIFTY AUTO27,698.75-0.04%NSE |
NIFTY FMCG45,592.15-0.66%NSE |
NIFTY PHARMA26,675.5+0.75%NSE |
NIFTY 50023,156.2-0.42%NSE |
WA
NSE · Equity shares · Furniture & Fixtures3.79 · 2.50%
Wakefit Innovations WAKEFIT
NSE:INR 155.34
BSE:INR 155.25
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for WAKEFIT
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 151.55
Day rangeINR 151.7 — INR 157.48
52-week rangeINR 111.4 — INR 224
Volume10.53 L
Market cap4,299.06
P/E26.22
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,488.94
Net Income (INR Cr)189.18
Rev Growth (5 Year %)29.51
P/E Ratio26.22
Book Value34.27
EPS6.08
Price/BV4.53Computed
Research path: Interpret Wakefit Innovations's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
WAKEFITWakefit Innovations1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,751.2 | 1,050.75 | 928.3 |
| Cash Equivalents | 88.49 | 0 | 0 |
| Other Liabilities Total | 8.92 | 8.46 | 7.58 |
| Common Stock Total | 33 | 1.05 | 1.03 |
| Preferred Stock-Non Redeemable Net | 0 | 19.24 | 19.24 |
| Other Current Assets Total | 29.99 | Not available | Not available |
| Total Assets | 1,751.2 | 1,050.75 | 928.3 |
| Current Portof LT Debt/Capital Leases | 80.91 | 70.99 | 44.91 |
| Total Equity | 1,131.82 | 520.57 | 543.61 |
| Long Term Investments | 351.67 | 89.04 | 12.99 |
| Retained Earnings(Accumulated Deficit) | 1,098.82 | -296.76 | -264.21 |
| Total Common Shares Outstanding | 33 | 32.68 | 32.68 |
| Tangible Book Valueper Share Common Eq | 34.27 | 15.31 | 16.03 |
| Total Liabilities | 619.38 | 530.18 | 384.69 |
| Total Debt | 271.88 | 273.33 | 189.9 |
| Short Term Investments | 574.64 | 299.23 | 389.59 |
| Cashand Short Term Investments | 663.12 | 306.35 | 393.22 |
| Total Receivables Net | 2.2 | 58.26 | 37.94 |
| Accounts Receivable-Trade Net | 2.2 | 5.86 | 28.09 |
| Property/Plant/Equipment Total-Net | 389.64 | 415.24 | 330.94 |
| Total Current Liabilities | 419.5 | 319.38 | 239.48 |
| Total Inventory | 197.55 | 167.94 | 134.72 |
| Accounts Payable | 194.06 | 157.01 | 144.42 |
| Other Currentliabilities Total | 144.53 | 55.73 | 37.59 |
| Total Long Term Debt | 190.96 | 202.34 | 137.63 |
| Intangibles Net | 1.13 | 0.91 | 0.58 |
| Other Long Term Assets Total | 109.77 | 0.45 | Not available |
| Note Receivable-Long Term | 6.13 | 7.64 | 9.68 |
| Total Current Assets | 892.86 | 537.48 | 574.12 |
| Capital Lease Obligations | 190.96 | 202.34 | 137.63 |
| Accumulated Depreciation Total | Not available | -195.48 | -124.27 |
| Accrued Expenses | Not available | 35.65 | 5.2 |
| Prepaid Expenses | Not available | 4.93 | 8.25 |
| Additional Paid-In Capital | Not available | 797.03 | 787.54 |
| Cash | Not available | 7.12 | 3.63 |
| Property/Plant/Equipment Total-Gross | Not available | 609.99 | 453.07 |
| Notes Payable/Short Term Debt | Not available | 0 | 7.36 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m5.03
Operating Margin 5y Avg-4.46
Net Profit Margin 12m12.71
Net Profit Margin 5y-2.18
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio2.89
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk54.32
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sheela Foam | INR 698.3 | 7,683.34 | 53.81 | — |
| Stanley Lifestyles | INR 153.45 | 876.88 | 61.97 | — |
| Elin Electronics | INR 102.25 | 508.53 | 22.64 | — |
| Pil Italica Lifestyle | INR 8.64 | 203.04 | 48.66 | — |
| Dhanashree Electronics | INR 132.65 | 188.23 | 90.2 | — |
Shareholding
Ownership
- Promoter
- 36.88%
- FII
- 14.48%
- MF
- 14.17%
- Other
- 34.47%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Wakefit Innovations IPO listing date today — What GMP, experts signal about share debutMarket news · 15 Dec 2025, 6:09 am
Wakefit Innovations IPO: After receiving 2.52 times oversubscription in its bidding rounds, the Wakefit Innovations public issue is set to hit Dalal Street on Monday, 15 December 2025. Here's what GMP experts signal about the share debut.
Wakefit Innovations IPO listing tomorrow. Here's what GMP signalsMarket news · 14 Dec 2025, 3:56 pm
After receiving a moderate response during the three-day subscription period, the shares of Wakefit Solutions are trading at a premium of ₹ 7, as per Investorgain.
Upcoming IPOs: KSH International IPO among four new issues, 15 listings scheduled for next week; check full list hereMarket news · 14 Dec 2025, 11:51 am
Upcoming IPOs: Meanwhile, Wakefit Innovations IPO, Corona Remedies IPO, Nephrocare Health IPO and others will make their stock market debut in the upcoming week.
Muted debut likely! Wakefit IPO GMP signals no listing gains- Check final subscription status, key detailsMarket news · 12 Dec 2025, 10:50 am
Wakefit Innovations IPO has finalized its allotment process, with shares set to debut on December 15 on BSE and NSE. The IPO saw a 2.52 times subscription, and the grey market indicates a steady start at ₹ 195 per share.
Wakefit Innovations IPO allotment finalised. GMP, steps to check share allotment status onlineMarket news · 12 Dec 2025, 6:27 am
Wakefit Innovations IPO attracted significant investor interest with allotment on December 11, 2025. Shares will list on BSE and NSE on December 15, following a successful subscription. Investors can check allotment status online, while the company raised ₹ 1,288.89 crore through the issue.
Wakefit Innovations IPO: GMP drops sharply! Issue receives 2.52 times bids on final dayMarket news · 10 Dec 2025, 5:51 pm
Wakefit's IPO, launched on December 10, was oversubscribed 2.52 times, driven by strong retail interest. The company reported ₹ 724 crore in revenue and ₹ 35.5 crore profit for the six months ending September 2025, with promoter shareholding set to drop to 37%.
Corporate actions
Events
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- annual General MeetingPOM
ShareKeyX Community
Discussion and sentiment for Wakefit Innovations
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Wakefit Innovations Limited is a direct-to-consumer(D2C) home and furnishings company engaged in the business of manufacturing, packaging, distribution, marketing and sale of mattresses, furniture and furnishings and decor. Its mattress product category includes memory foam, latex, grid, and high-resilience foam models such as dual comfort, spring, plus, rollup, and foldable options. The furniture product category includes beds (including engineered wood, natural wood and metal beds), sofas and recliners, wardrobes, dining tables, chairs and seating (including office chairs, gaming chairs and ottomans), cabinets, tables, shelves, kids’ furniture including cribs and utility furniture. The furnishings product category includes pillows and cushions, home essentials such as towels, mats, rugs and carpets, yoga mats, runners, curtains, bathrobes, bean bags, deck tiles, dinnerware, kitchenware, service ware, mattress protectors, table linen, mirrors and home decor.
Company facts
- Industry
- Furniture & Fixtures
- Sector
- Furniture & Fixtures
- NSE Code
- WAKEFIT
- BSE Code
- 544642
Questions
Stock FAQ
What is the symbol and ISIN of Wakefit Innovations?
Wakefit Innovations has the symbol WAKEFIT and ISIN - INE0E7301029.
What is the current price of Wakefit Innovations?
Wakefit Innovations is currently trading at INR 155.34.
What are the year high and year low of Wakefit Innovations?
Wakefit Innovations has a year high of INR 224.00 and a year low of INR 111.40.
What is the market capitalization of Wakefit Innovations?
Wakefit Innovations has a market capitalization of INR 4,299.06 crore.
What is the P/E ratio of Wakefit Innovations?
Wakefit Innovations has a P/E ratio of 26.22.
What is the dividend yield of Wakefit Innovations?
Wakefit Innovations has a dividend yield of 0.00%.
How is the financial performance of Wakefit Innovations based on revenue, net income, and EPS?
Wakefit Innovations has revenue of INR 1,488.94 crore, net income of INR 189.18 crore, and EPS of INR 5.89.
What is the book value of Wakefit Innovations?
Wakefit Innovations has a book value of INR 34.27.
What is the debt-to-equity ratio of Wakefit Innovations?
Wakefit Innovations has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Wakefit Innovations?
Wakefit Innovations has a price-to-book ratio of 4.53 and a price-to-sales ratio of 2.89.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.